Boston Scientific (BSX): Bridgewater Associates reduced its stake -4,828 shares
Bridgewater Associates reduced its stake in Boston Scientific, per its Q3 2026 13F.
- 437K
- Shares reported · -4,828 vs prior quarter
- 0.08%
- Disclosed portfolio weight
- $19.1M
- Reported value
- Holdings as of
- Sep 30, 2026
- Filed
- Nov 16, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 31, 2026CongressDisclosed sale of BSX — reported range $15,001 - $50,000
- Sep 3, 2026Congress · 1 personMembers of Congress: 3 sales
- Sep 4, 2026CongressDisclosed partial sale of BSX — reported range $50,001 - $100,000
- Sep 9, 2026CongressDisclosed sale of BSX — reported range $50,001 - $100,000
- Sep 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027.”
- Sep 30, 2026FDARecall: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation System
- Oct 1, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 7, 2026, Boston Scientific Corporation (the “Company”) announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027.”
- Oct 1, 2026Federal contract · $1.0M obligatedDepartment of Veterans Affairs awarded Boston Scientific: $1.05M obligated to date
- Oct 1, 2026Federal contract · $880K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $880K obligated to date
- Oct 1, 2026Federal contract · $832K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $832K obligated to date
- Oct 1, 2026Federal contract · $524K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $524K obligated to date
- Oct 1, 2026Federal contract · $465K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $465K obligated to date
- Oct 28, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
How this filing works
Explore the data
Common questions
What does this filing report about Boston Scientific (BSX) stock?
Bridgewater Associates reduced its stake in Boston Scientific, per its Q3 2026 13F. Now 437K shares, $19.1M reported value, 0.08% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2026. Filed: Nov 16, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- House Clerk periodic transaction reportSep 25, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
